MedTech News
Less invasive brainwave recording uses blood vessels to access activity with unprecedented precision
Researchers at the University of Osaka have developed a minimally invasive method for recording brain activity through blood vessels.
Novel gene editing technology enables selective destruction of cancer cell DNA using fewer targets
Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy.
Diagnostic tool enables rapid leukemia subtype classification
Researchers at Dana-Farber Cancer Institute have developed a diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided Rapid Leukemia Subtype Inference), uses DNA methylation patterns and machine learning to classify acute leukemia with speed and accuracy
Engineered gut bacteria improve survival outcomes in colorectal cancer tumors
In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Central South University in China have developed an engineered strain of gut-homing bacteria that stimulates potent antitumor immune responses against colorectal cancer (CRC).
Experimental eyedrop formula delivers protective compounds for serious vision problems
A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions.
Deep brain stimulation sustains motor gains over 5 years in Parkinson disease
The INTREPID study group, a team of 49 researchers from 30 academic and medical institutions, reports on sustained five-year benefits from subthalamic nucleus deep brain stimulation for Parkinson’s disease. They find improved motor function and daily living activities with a 28% reduction in anti-Parkinson’s medication.
FDA clears Techsomed BioTraceIO360 for kidney ablation
Techsomed this week announced it received FDA 510(k) clearance to expand indications for its BioTraceIO360 software platform to include percutaneous ablation of soft tissue in the kidney.
Brainlab unveils FDA-approved spine mixed reality navigation in US
The system leverages the company’s optical navigation system technology and the latest advancements in mixed reality.